Poland· PL-100502048
Filspari
A c09x, c09xx01 product containing sparsentanum, registered in Poland by Vifor France.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Sparsentanum
- Manufacturer
- Vifor France
- Country
- Poland (PL)
- ATC code
- C09X, C09XX01
- ATC class
- C09X, C09XX01
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin04150188291991
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sparsentanum in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFILSPARIVifor France, Paris
- SwitzerlandFilspari 200 mg, FilmtablettenVifor (International) Inc.
- SpainFILSPARI 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULAVifor France
- FinlandFILSPARIVifor France
- IrelandFilspari 200 mg film-coated tabletsVifor France
- IcelandFilspariVifor France
- NetherlandsFilspari 200 mg filmomhulde tablettenVifor France
- NorwayFilspariVifor France
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Filspari
- Liechtenstein · Filspari
- Norway · Filspari
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/15ea8f20-20be-46e6-855a-af86007a34d5 GET /v1/drugs/15ea8f20-20be-46e6-855a-af86007a34d5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "200 mg",
"packaging": "Rp ¦ EU/1/23/1788/001 ¦ 157346\n30 tabl.\n¦ UR/Z/4b/286/25 - 04150188291991 ¦ UR/Z/4b/335/25 - 04150188291991",
"substance": "Sparsentanum 200 mg",
"common_name": "Sparsentanum",
"pl_product_id": "100502048",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about sparsentanum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.